↓ Skip to main content

MicroRNA-7: a promising new target in cancer therapy

Overview of attention for article published in Cancer Cell International, October 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter
4 X users
patent
2 patents

Citations

dimensions_citation
95 Dimensions

Readers on

mendeley
97 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MicroRNA-7: a promising new target in cancer therapy
Published in
Cancer Cell International, October 2015
DOI 10.1186/s12935-015-0259-0
Pubmed ID
Authors

Juanjuan Zhao, Yijing Tao, Ya Zhou, Nalin Qin, Chao Chen, Dan Tian, Lin Xu

Abstract

The incidence of tumors with life-threatening effects has increased gradually over time; however, the mechanisms involved in tumor development have not been fully elucidated. Recent studies have shown that microRNA-7 (miR-7), which is endogenous non-coding RNA molecules of approximately 23 nucleotides, plays an important role in the occurrence and development of tumors as a key tumor suppressor. Mechanistic evidence showed that miR-7 is closely related to the growth, metastasis, and prognosis of various malignant tumors through regulating different target molecules, which suggest that miR-7 may be a new target for the clinical diagnosis and treatment of various tumors. In this review, we summarize current knowledge of the relationship between miR-7 and tumor development, diagnosis, and treatment.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
Portugal 1 1%
Ghana 1 1%
Brazil 1 1%
Unknown 93 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 24 25%
Student > Master 15 15%
Student > Bachelor 10 10%
Researcher 10 10%
Student > Doctoral Student 8 8%
Other 10 10%
Unknown 20 21%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 31 32%
Agricultural and Biological Sciences 21 22%
Medicine and Dentistry 9 9%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Immunology and Microbiology 3 3%
Other 9 9%
Unknown 21 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 September 2019.
All research outputs
#5,832,044
of 23,411,993 outputs
Outputs from Cancer Cell International
#538
of 1,856 outputs
Outputs of similar age
#71,947
of 286,078 outputs
Outputs of similar age from Cancer Cell International
#4
of 26 outputs
Altmetric has tracked 23,411,993 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 1,856 research outputs from this source. They receive a mean Attention Score of 4.0. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 286,078 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.